SEC Form 4 · accession 0001651844-15-000009
NYMOX PHARMACEUTICAL CORP · NYMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James George Robinson
Director
Period of report
Dec 21, 2015
Accepted (ET)
Dec 24, 2015 · 11:02 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001018735
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 21, 2015 | P | 10,000 | $3.77 | A | 2,497,696 | D | |
| Common Stock | Dec 22, 2015 | P | 700 | $3.51 | A | 2,498,396 | D | |
| Common Stock | Dec 23, 2015 | P | 9,944 | $3.37 | A | 2,508,340 | D | |
| Common Stock | Dec 23, 2015 | P | 9,210 | $3.46 | A | 2,517,550 | D | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust |
Table II — derivative securities
No Table II lines on this filing.